Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.
about
Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysisAdjuvant Chemoradiation Therapy in Gastric Cancer: Critically Reviewing the Past and Visualizing the Next Step ForwardComparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer.Dose-dependent changes in renal (1)H-/(23)Na MRI after adjuvant radiochemotherapy for gastric cancer.Adjuvant Chemotherapy with Docetaxel, Cisplatin, and Continuous-Infusion 5-Fluorouracil for Gastric Cancer: A Phase II Study.Adjuvant therapy for gastric cancer: current and future directions.Proton therapy in adjuvant treatment of gastric cancer: planning comparison with advanced x-ray therapy and feasibility report.Postoperative chemoradiotherapy vs. preoperative chemoradiotherapy for locally advanced (operable) gastric cancer: clarifying the role and technique of radiotherapy.Evaluation of internal target volume in patients undergoing image-guided intensity modulated adjuvant radiation for gastric cancersPostoperative chemo-radiotherapy versus chemotherapy for resected gastric cancer: a systematic review and meta-analysis.Adjuvant and neoadjuvant options in resectable gastric cancer: is there an optimal treatment approach?Optimal management of resectable gastric adenocarcinoma.Perioperative chemotherapy versus postoperative chemoradiotherapy in patients with resectable gastric/gastroesophageal junction adenocarcinomas: A survival analysis of 5058 patients.Progress in the treatment of advanced gastric cancer.Prognostic effect of adjuvant chemoradiotherapy for patients with gastric cancer: an updated evidence of randomized controlled trials.Outcomes of radiation therapy for resectable M0 gastric cancer.Progress of preoperative and postoperative radiotherapy in gastric cancer
P2860
Q26738505-0B247A48-5EF9-4AEF-8F6C-CB2A42D8E70FQ26858776-8ECB7BE2-323C-4C1D-ABAD-984F6BCD04EFQ30248541-A79E37F0-C299-40BC-AD30-081C35C22CFEQ30872867-9554FA4A-17A1-454B-B54D-AA2D3F4ECB4EQ33912309-45DFD09F-C7D7-4951-89ED-892A15A63987Q34326579-E48E49B6-1A15-4EDC-8E9F-8187976E5DDEQ34418908-1BD8EC01-54EB-460A-A985-B4DCA37A9553Q34962091-C7494447-A4C7-4566-9DFF-5597CFD35DC1Q37504866-9EB6A220-952D-4787-8FC9-D96BBB7576B8Q38226324-9D7D27D5-F766-496E-8E6D-1527A2C16BE8Q38364619-EB8724EF-AE57-465D-80FA-C497C44505C0Q38545533-A8E68F82-8188-414C-8713-CFB6951B2ABEQ38848598-8DC42E5E-4B6B-412F-997F-CD4E7E913E4BQ39410760-A5458AC5-8042-4294-9293-F7E8AEBB62CCQ47157584-68029658-36B7-4337-BB86-FF930826CD65Q49164896-C810D024-F4CB-454D-ACE4-EB3360CC133AQ58743551-02B87DE1-9217-4224-BC74-FCA32EC7EC28
P2860
Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.
@en
type
label
Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.
@en
prefLabel
Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.
@en
P2093
P2860
P1476
Who benefits from adjuvant radiation therapy for gastric cancer? A meta-analysis.
@en
P2093
Andreas Kaubisch
Chandan Guha
Madhur K Garg
Nitin Ohri
Santiago Aparo
Shalom Kalnicki
Timothy J Kennedy
P2860
P304
P356
10.1016/J.IJROBP.2013.02.008
P407
P50
P577
2013-03-20T00:00:00Z